Treat 4 Ramadan: A Randomised Control Trial Comparing Liraglutide vs. a Sulphonylurea as Add-On to Metformin in Patients With Established Type 2 Diabetes

被引：0
|
作者：
Davies, Melanie J.
Brady, Emer M.
Gray, Laura J.
Saeed, Mujahid
Wasim, Hanif
Khunti, Kamlesh
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2599-PO
引用
收藏
页码：A661 / A661
页数：1
相关论文
共 50 条
  • [31] Treatment adherence with vildagliptin compared to sulphonylurea as add- on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan
    Hanif, W.
    Malik, W.
    Hassanein, M.
    Kamal, A.
    Geransar, P.
    Andrews, C.
    Azam, M.
    Barnett, A. H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (07) : 807 - 811
  • [32] Liraglutide as add-on to metformin in type 2 diabetes: significant improvement in glycaemic control with a reduction in body weight compared with glimepiride
    Nauck, M
    Hompesch, N
    Filipczak, R
    Le, TTD
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETOLOGIA, 2004, 47 : A281 - A281
  • [33] Liraglutide significantly improves glycemic control and reduces body weight compared with glimepiride as add-on to metformin in type 2 diabetes
    Nauck, MA
    Hompesch, M
    Filipczak, R
    Le, TDT
    Nielsen, L
    Zdravkovic, M
    Gumprecht, J
    DIABETES, 2004, 53 : A83 - A83
  • [34] LIRA-PRIME: A Randomized Trial in Primary Care Settings of Liraglutide vs. OAD for Glycemic Control in Patients with Type 2 Diabetes Not in Control on Metformin
    Unger, Jeff
    Kaltoft, Margit
    Kolhe, Devayani
    Panda, Jayant Kumar
    Sargin, Mehmet
    Wolthers, Benjamin Ole
    Zoghbi, Marouan
    DIABETES, 2020, 69
  • [35] CHOICE OF THE ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN ROMANIA
    Brozi, J.
    Brunerova, L.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (03) : 375 - 375
  • [36] Empagliflozin as add-on to pioglitazone with or without metformin in patients with Type 2 diabetes
    Kovacs, C. S.
    Seshiah, V.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Stella, P.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 88 - 88
  • [37] Empagliflozin as add-on to metformin plus sulfonylurea in patients with Type 2 diabetes
    Haering, H. U.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [38] Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
    Anwar, D.
    Bao, Y.
    Zhou, Y.
    Chen, S.
    Zhou, J.
    Li, L.
    Cheng, Z.
    Dong, X.
    Shi, X.
    Zhao, N.
    Yang, Y.
    Ma, J.
    Li, Y.
    Wang, Q.
    Jia, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S322
  • [39] Efficacy and Safety of Supaglutide as Add-on to Metformin in Patients with Type 2 Diabetes
    Anwar, Dilbar
    Bao, Yuqian
    Zhou, Yue
    Chen, Si
    Zhou, Jian
    Li, Liang
    Cheng, Zhifeng
    Dong, Xiaolin
    Shi, Xiaoxia
    Su, Xiuhai
    Li, Liping
    Wang, Haifang
    Wang, Yihua
    Li, Shu
    Li, Qingju
    Li, Xing
    Liu, Ming
    Sun, Jiao
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Wang, Qinghua
    Jia, Weiping
    DIABETES, 2023, 72
  • [40] Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
    Mendez-del Villar, Miriam
    Martinez-Abundis, Esperanza
    Preciado-Marquez, Rafael O.
    Gonzalez-Ortiz, Manuel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (02): : 188 - 192
12345